Back to resultsFatty Acid Quality and Overweight (FO-study)
Primary Purpose
Weight Reduction and Insulin Sensitivity
Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
fatty acid quality and overweight
Sponsored by
About this trial
This is an interventional basic science trial for Weight Reduction and Insulin Sensitivity
Eligibility Criteria
Inclusion Criteria:
- no use of medication, healthy, 27<BMI<40
Exclusion Criteria:
- pregnant and lactating women, chronic diseases.
Sites / Locations
- Akershus University College
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Placebo Comparator
Experimental
Experimental
Arm Label
Low intake of ALA and triacylglycerols
high intake of ALA and triacylglyceroles
high intake of ALA and diacylglycerols
Arm Description
Sunflower oil
Canola and linseed oils
Canola and linseed oils
Outcomes
Primary Outcome Measures
Will intake of fat as diacylglycerols give weight reduction in overweight individuals?
Secondary Outcome Measures
Will a high intake of ALA involve reduced levels of inflammatory markers?
Will a high intake of ALA involve changes in insulin sensitivity?
Full Information
NCT ID
NCT01034436
First Posted
December 16, 2009
Last Updated
June 17, 2015
Sponsor
Oslo Metropolitan University
1. Study Identification
Unique Protocol Identification Number
NCT01034436
Brief Title
Fatty Acid Quality and Overweight (FO-study)
Official Title
Fatty Acid Quality and Overweight
Study Type
Interventional
2. Study Status
Record Verification Date
June 2015
Overall Recruitment Status
Completed
Study Start Date
February 2009 (undefined)
Primary Completion Date
June 2009 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Oslo Metropolitan University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to study the health effects of fatty acid quality in healthy, overweight individuals.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Weight Reduction and Insulin Sensitivity
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
41 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Low intake of ALA and triacylglycerols
Arm Type
Placebo Comparator
Arm Description
Sunflower oil
Arm Title
high intake of ALA and triacylglyceroles
Arm Type
Experimental
Arm Description
Canola and linseed oils
Arm Title
high intake of ALA and diacylglycerols
Arm Type
Experimental
Arm Description
Canola and linseed oils
Intervention Type
Dietary Supplement
Intervention Name(s)
fatty acid quality and overweight
Intervention Description
Duration 12 weeks
Primary Outcome Measure Information:
Title
Will intake of fat as diacylglycerols give weight reduction in overweight individuals?
Time Frame
baseline (0 weeks), 12 weeks
Secondary Outcome Measure Information:
Title
Will a high intake of ALA involve reduced levels of inflammatory markers?
Time Frame
baseline (0 weeks), 12 weeks
Title
Will a high intake of ALA involve changes in insulin sensitivity?
Time Frame
baseline (0 weeks), 12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
no use of medication, healthy, 27<BMI<40
Exclusion Criteria:
pregnant and lactating women, chronic diseases.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stine Marie Ulven, PhD
Organizational Affiliation
University Hospital, Akershus
Official's Role
Study Chair
Facility Information:
Facility Name
Akershus University College
City
Oslo
State/Province
Lillestrom
ZIP/Postal Code
2001
Country
Norway
12. IPD Sharing Statement
Citations:
PubMed Identifier
32386512
Citation
Telle-Hansen VH, Christensen JJ, Formo GA, Holven KB, Ulven SM. A comprehensive metabolic profiling of the metabolically healthy obesity phenotype. Lipids Health Dis. 2020 May 9;19(1):90. doi: 10.1186/s12944-020-01273-z.
Results Reference
derived
Learn more about this trial
Fatty Acid Quality and Overweight (FO-study)
We'll reach out to this number within 24 hrs